A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence
Status:
Completed
Trial end date:
1997-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to is to evaluate the safety and efficacy of OROS® oxybutynin
chloride in patients being treated for urge urinary incontinence. Oxybutynin is an
antispasmodic, anticholinergic medication for the treatment of the symptoms of overactive
bladder.